A year ago I presented the results of the PARTNER gBRCA WT cohort at #AACR2024 with a concomitant publication of the results here https://t.co/3tnmpHouwj
Today, our second paper from the trial is out 🙌🙌🙌🙌
Check it out!! https://t.co/WueDhz5O06
A year ago I presented the results of the PARTNER gBRCA WT cohort at #AACR2024 with a concomitant publication of the results here https://t.co/3tnmpHouwj
Today, our second paper from the trial is out 🙌🙌🙌🙌
Check it out!! https://t.co/WueDhz5O06
A year ago I presented the results of the PARTNER gBRCA WT cohort at #AACR2024 with a concomitant publication of the results here https://t.co/3tnmpHouwj
Today, our second paper from the trial is out 🙌🙌🙌🙌
Check it out!! https://t.co/WueDhz5O06
🔊Results from the PARTNER Trial hereditary BRCA #breastcancer cohort results have just been published in @NatureComms: https://t.co/lMHPRtsmir. A great read alongside the #TNBC result: https://t.co/LFTv80C16F. Thanks to all the patients that took part.
The results of the PARTNER Trial Hereditary BRCA 1 and 2 related breast cancer cohort are now out in @NatureComms 👉🏼 https://t.co/lMHPRtsmir Read alongside the TNBC results for the full story https://t.co/LFTv80C16F. Thanks to the amazing patients that took part.
📡The first paper from the #PARTNER Clinical Trial, led by @JeanEAbraham722, has just been published in @Nature. Thanks to all the patients who took part & their families/supporters, also the centres & teams across the UK that recruited to the study.🧵 https://t.co/LFTv80C16F.
Results from the Triple Negative Breast Cancer cohort in the PARTNER trial led by Prof @JeanEAbraham722@CUH_NHS@Cambridge_Uni – testing olaparib with chemotherapy prior to surgery – are presented today at #AACR24 and published in @Nature.
@CRUKresearch
https://t.co/N30J1WPe72
Another one from the lab! Great talk by @SoleilmaneO at the Cambridge Precision Breast Cancer Symposium describing novel approaches he has developed to look at metastasis in breast cancer #CPBC2023 @CRUKCamBreast
Great couple of poster talks from Kirsty Sawicka on the IMAXT project and @KarenAndreaPi on the Personalised Breast Cancer Programme taking us into the lunch break and poster session
#CPBC2023
Great to hear from our own @KarenAndreaPi at the Cambridge Precision Breast Cancer Symposium about new insights on the PARTNER trial! If you are around, check her poster too #CPBC2023
Congratulations @AndresC27622123 for assuming the presidency of @myESMO Your brilliant career and your vocation for training will guide you successfully through this stage. Proud that a Spanish colleague is once again leading the Europan reference institution for medical oncology
📢 Don't miss the first in-person event organised by @CRUKCamBreast#CPBC2023
Join us to hear from national and international breast cancer experts on recent advances and future challenges!
Register here 👉 https://t.co/Sm1L9FVufL
The Carroll lab is looking for an enthusiastic lab manager! Come join our fantastic team. Please follow link below to apply. Spread the word! @JCarrollLab@CRUK_CI https://t.co/mqDyBkNo5X
Super proud of the Precision Breast Cancer Institute team who won a Team Excellence Award at todays @NIHRCRNeoe Cancer Research Conference. Well done 👏👏👏 @CRUKCamCentre
Here is an exciting opportunity for a postdoc to join my group for this project funded by @CR_UK : Associate (Fixed Term) - Job Opportunities - University of Cambridge https://t.co/SpXUggdLiR
We are delighted to offer two fully funded studentships @Cambridge_Uni in the 'Black Leaders in Cancer PhD Scholarship Programme' - a new initiative from @CRUKResearch in partnership with @Windsor_Fellows and @BlackinCancer
Applications open 1 Oct
👉 https://t.co/aG7hH0EsYA